The study, published on July 15 in eClinical Medicine, shows that GLP-1RAs can lead to moderate reductions in binge eating severity, loss of control eating, and emotional eating
In rare cases, it could increase the risk of pancreatitis
Preclinical studies with a long-acting polyethylene glycosylated (PEGylated) FGF21 analog, B1344, in non-human primates with non-alcoholic liver disease demonstrated reduction of steatosis, attenuation of inflammation and fibrosis, and reduced hepatocyte injury after 11 weeks of therapy as assessed by analyzing liver biopsies [36]
KFF Health/Health Misinformation Tracking Poll (April 23May 1, 2024)
Medical transformation The medical before and after is often the most objectively impressive aspect of GLP-1 transformation
Synthesis and amylin receptor activity of glycomimetics of pramlintide using click chemistry